PINK News | Roxom Stocks

Invest Private Security Newsroom

Market Overview

Indices and commodities.

Bitcoin treasury preferreds.

The artificial intelligence theme.

Bitcoin Treasuries

Companies holding bitcoin.

Sectors, global markets and rates.

Popular Portfolios

13F filings, smart money.

Borrow USDT or USDC against your BTC without giving it up.

Switch your bitcoin-backed loan and pay less interest.

Borrow, invest, keep the spread.

Stock Dividends

Dividends from tokenized equities.

Company

Our leadership team, mission, and investors.

Vision, purpose, and architecture behind Roxom.

Terms, privacy, and disclosures.

Resources

Guides, FAQs & support.

Trading logic, platform rules, and fundamentals.

Connect, authenticate, and build with our API.

Current platform health and incidents.

Loading chart

Pay with

1 BTC

=

- USD

Loading market data...

Loading chart

Pay with

PI

Volume

47.45K

Loading chart

PI

PINKSimplify Health Care ETF

PINK

Pay with—

Available Balance0.00

PI

AUM

N/A

Volume

47.45K

Yield

1.05%

Chart Earnings News About Dividends Insider Filings

Which Healthcare ETF Is the Better Buy: Simplify’s Active PINK or VanEck’s Pharma-Focused PPH?The article compares two healthcare ETFs: VanEck Pharmaceutical ETF (PPH) offers lower costs (0.36% expense ratio), higher dividends (1.9% yield), and a concentrated portfolio of 26 pharmaceutical companies with an established 15-year track record. Simplify Health Care ETF (PINK) provides broader healthcare exposure through active management of 58 positions with a unique charitable structure donating profits to cancer research, though it carries higher fees (0.51%) and lower yields (0.8%). For most long-term investors, PPH is recommended for its fundamentals, while PINK appeals to those seeking active management and charitable impact.The Motley Fool · Oct 11, 2026

Vanguard Health Care ETF vs Simplify Health Care ETFVanguard Health Care ETF (VHT) offers broad healthcare exposure with a low 0.09% expense ratio and 1.5% dividend yield, while Simplify Health Care ETF (PINK) provides active management with higher 1-year returns (32.4% vs 29.3%) but charges 0.51% in fees. The author recommends Simplify despite Vanguard's better year-to-date performance, citing Simplify's superior longer-term returns and its pro bono model donating profits to breast cancer research.The Motley Fool · Sep 1, 2026

Simplify's PINK or iShares' IYH: Which Healthcare ETF Should Long-Term Investors Choose Right Now?Simplify Health Care ETF (PINK) has delivered superior 1-year returns of 42% versus iShares U.S. Healthcare ETF's (IYH) 31.4%, driven by active management focused on healthcare innovation and a charitable mission donating profits to cancer research. However, IYH offers lower costs (0.38% vs 0.51% expense ratio), higher dividend yield (1.1% vs 0.6%), and a proven 25+ year track record, making it the more suitable choice for most long-term conservative investors despite PINK's recent outperformance.The Motley Fool · Aug 13, 2026

iShares U.S. Pharmaceuticals ETF Tops Simplify Health Care ETF ReturnsThe iShares U.S. Pharmaceuticals ETF (IHE) outperformed the Simplify Health Care ETF (PINK) over the past year, delivering 42.40% returns versus 29.30%. IHE offers lower costs (0.38% expense ratio), higher dividend yield (1.62%), and focuses on established pharmaceutical giants like Eli Lilly and Johnson & Johnson. While PINK provides active management with innovation focus and donates profits to breast cancer research, its higher expense ratio (0.51%) and recent underperformance give IHE the edge for 2026.The Motley Fool · Jun 10, 2026

Billionaire Investor Takes New Stake In Thermo Fisher ScientificHedge fund billionaire Daniel Loeb's Third Point LLC acquired a stake in Thermo Fisher Scientific (TMO) in Q4 2025, purchasing 50,000 shares. The company reported strong Q1 2026 earnings of $5.44 per share, beating expectations, with 6% YoY revenue growth to $11.01 billion. TMO raised full-year guidance for both earnings and sales. However, the stock remains under technical pressure, trading 13.7% below its 100-day moving average with mixed momentum indicators.Benzinga · Apr 30, 2026

'Own what the Mother of All Bubbles crowd doesn't': This market strategist expects stagflation and is investing for it now."The bond market is saying the Fed is going to remain tight and seriously consider another rate hike in September," strategist Keith McCullough says.MarketWatch · Aug 26, 2023

'The Fed is way late and they’ve already screwed it up.' This stock strategist is banking on gold, silver and Treasurys to weather a recession.Hedgeye's Keith McCullough says the market is in denial: 'Investors just want their bubble back.'MarketWatch · May 13, 2023

ETFs in Focus on Sanofi and Regeneron's COPD Drug DataShares of drugmakers Sanofi and Regeneron surged more than 6% on Mar 23 on COPD drug data.Zacks Investment Research · Mar 24, 2023

ETFs to Buy on UnitedHealth's Q2 Earnings BeatUnitedHealth reported better-than-expected second-quarter 2022 results, breezing past the Zacks Consensus Estimate for both earnings and revenues. The company lifted its full-year earnings guidance for the second straight quarter.Zacks Investment Research · Jul 18, 2022

Healthcare ETFs to Gain on UnitedHealth's Solid Q1 EarningsUnitedHealth reported better-than-expected first-quarter 2020 results, breezing past the Zacks Consensus Estimate for both earnings and revenues. The company lifted its full-year earnings guidance.Zacks Investment Research · Apr 18, 2022

to start trading

PI

PINKSimplify Health Care ETF

PINK

Pay with—

Available Balance0.00

Your PositionYou don't own any PINK yet.

Related Tickers

Earnings

Dividends

Last · Sep 25Quarterly

Amount$0.10

Yield0.79%

Annual$0.30